BioSpace News Archive

Drug Development

Veru Announces Oral Late-Breaking Presentation of Phase 2 Data of Sabizabulin for the Treatment of Hospitalized Severe COVID-19 Patients

Veru Inc. today announced that results from the randomized placebo-controlled Phase 2 study of daily were presented at the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) being held in Lisbon, Portugal on April 23-26, 2022.

April 25, 2022
·
12 min read
Business

Radius Health to Release First Quarter 2022 Financial Results, Host Conference Call and Live Webcast on Thursday, May 5, 2022

Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) announced today that it will release its first quarter 2022 financial results on Thursday, May 5, 2022.

April 25, 2022
·
1 min read
Deals

NIDO Surgical Announces the Acquisition of SEPIA Device

NIDO Surgical announced today the acquisition of its innovative epicardial ablation technology, SEPIA (Solution for Epicardial Ablation), by an undisclosed medical device company involved in the electrophysiology space.

April 25, 2022
·
3 min read
Biotech Bay

Minimal Side Effects and Short Recovery Time Reported for DSUVIA®-Treated Patients: Plastic Surgery Podium Presentation at The Aesthetic Meeting 2022

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (“AcelRx”), today announced a summary of results from a podium presentation on DSUVIA® (sufentanil sublingual tablet (SST), 30 mcg) presented at the annual meeting of The Aesthetic Society®, “The Aesthetic Meeting 2022".

April 25, 2022
·
5 min read
BioCapital

GemPharmatech, Leading Provider of Genetically Engineered Mouse Models, Goes Public on Shanghai Stock Exchange

GemPharmatech LLC is pleased to announce that on April 25, 2022, its parent company, GemPharmatech Co., Ltd., went public on the STAR MARKET of the Shanghai Stock Exchange under the stock code 688046.

April 25, 2022
·
3 min read
Accelerate Diagnostics Presents New Data at ECCMID 2022 Demonstrating Rapid and Accurate Results Using Automated Accelerate Arc™ Module and BC Kit

Accelerate Diagnostics, Inc. today announced the release of new data on the Accelerate Arc Module and BC kit at the 32nd European Congress for Clinical Microbiology and Infectious Diseases (ECCMID) located in Lisbon, Portugal 23-26 April 2022.

April 25, 2022
·
5 min read
Lone Star Bio

Cassava Sciences Invited to Participate in B. Riley Securities’ Neuroscience Conference

Cassava Sciences, Inc. announced that it has been invited to participate in the B. Riley Securities’ Neuroscience Conference, a virtual event taking place on April 27-28, 2022.

April 25, 2022
·
1 min read
Biotech Bay

Dr. Henry Ji, Sorrento Therapeutics’ Chairman and CEO and Scilex Holding Company’s Executive Chairman, to Present at the B. Riley Securities’ 2022 Virtual Neuro & Opthalmology Healthcare Conference (April 27-28, 2022)

Sorrento Therapeutics, Inc. (NASDAQ: SRNE, “Sorrento”) today announced that Dr. Henry Ji, Chairman and CEO of Sorrento and Executive Chairman of Scilex Holding Company (“Scilex”), will participate in the B. Riley Virtual Neuro & Opthalmology Healthcare Conference at 10:00AM ET on April 27, 2022.

April 25, 2022
·
13 min read
Business

AffyImmune Therapeutics Announces Hiring of Dr. Sonal Gupta as Senior Vice President and Head of Clinical Development

AffyImmune Therapeutics, Inc. announced today the addition of Sonal Gupta , MD, PhD to its senior leadership team as Senior Vice President and Head of Clinical Development.

April 25, 2022
·
2 min read
Beaconcure to Share Insights on Clinical Trial Data Validation at PHUSE US Connect and PharmaSUG

Beaconcure has announced that this May, it will present at two major international conferences - PHUSE US Connect 2022 (May 1-4 in Atlanta, Georgia) and PharmaSUG 2022 (May 22-25 in Austin, Texas).

April 25, 2022
·
3 min read